1. Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party1. Issue 1 (23rd October 2018) Authors: Bazarbachi, Ali; Boumendil, Ariane; Finel, Hervé; Mohty, Mohamad; Castagna, Luca; Blaise, Didier; Peggs, Karl S.; Afanasyev, Boris; Diez‐Martin, J.L.; Corradini, Paolo; Michonneau, David; Robinson, Stephen; Gutiérrez García, Gonzalo; Bonifazi, Francesca; Yakoub‐Agha, Ibrahim; Gülbas, Zafer; Bloor... Journal: Cancer Issue: Volume 125:Issue 1(2019) Page Start: 90 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗